Pérez-Ruixo JJ - Search Results

1

Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients.

Pérez-Ruixo C, Valenzuela B, Fernández Teruel C, González-Sales M, Miguel-Lillo B, Soto-Matos A, Pérez-Ruixo JJ. Pérez-Ruixo C, et al. Cancer Chemother Pharmacol. 2012 Jan;69(1):15-24. doi: 10.1007/s00280-011-1644-6. Epub 2011 May 18. Cancer Chemother Pharmacol. 2012. PMID: 21590449 Clinical Trial.

2

Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates.

Dari A, Solforosi L, Roozendaal R, Hoetelmans RMW, Pérez-Ruixo JJ, Boulton M. Dari A, et al. Among authors: perez ruixo jj. J Pharmacol Exp Ther. 2023 Oct;387(1):121-130. doi: 10.1124/jpet.123.001591. Epub 2023 Aug 3. J Pharmacol Exp Ther. 2023. PMID: 37536955

3

Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans.

Dari A, Jacqmin P, Iwaki Y, Neyens M, Le Gars M, Sadoff J, Hardt K, Ruiz-Guiñazú J, Pérez-Ruixo JJ. Dari A, et al. Among authors: perez ruixo jj. CPT Pharmacometrics Syst Pharmacol. 2023 Oct;12(10):1485-1498. doi: 10.1002/psp4.13025. Epub 2023 Sep 15. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37715342 Free PMC article.

4

Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice.

Sandra L, T'jollyn H, Vermeulen A, Ackaert O, Perez-Ruixo JJ. Sandra L, et al. Among authors: perez ruixo jj. CPT Pharmacometrics Syst Pharmacol. 2024 May;13(5):729-742. doi: 10.1002/psp4.13129. Epub 2024 Mar 24. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38522000 Free PMC article. Review.

5

[Virtual clinical trials, fact or fiction?].

Pérez-Ruixo JJ, Valenzuela B. Pérez-Ruixo JJ, et al. Farm Hosp. 2005 May-Jun;29(3):153-7. doi: 10.1016/s1130-6343(05)73656-4. Farm Hosp. 2005. PMID: 16013940 Spanish. No abstract available.

6

Effect of CYP2D6 genetic polymorphism on the population pharmacokinetics of tipifarnib.

Perez-Ruixo JJ, Zannikos P, Ozdemir V, Franc MA, Francke S, Piotrovsky V. Perez-Ruixo JJ, et al. Cancer Chemother Pharmacol. 2006 Nov;58(5):681-91. doi: 10.1007/s00280-006-0215-8. Epub 2006 Mar 17. Cancer Chemother Pharmacol. 2006. PMID: 16544144 Clinical Trial.

7

Modelling intestinal absorption of salbutamol sulphate in rats.

Valenzuela B, López-Pintor E, Pérez-Ruixo JJ, Nácher A, Martín-Villodre A, Casabó VG. Valenzuela B, et al. Int J Pharm. 2006 May 11;314(1):21-30. doi: 10.1016/j.ijpharm.2006.01.019. Epub 2006 Mar 30. Int J Pharm. 2006. PMID: 16574353

8

Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients.

Perez-Ruixo JJ, Piotrovskij V, Zhang S, Hayes S, De Porre P, Zannikos P. Perez-Ruixo JJ, et al. Br J Clin Pharmacol. 2006 Jul;62(1):81-96. doi: 10.1111/j.1365-2125.2006.02615.x. Br J Clin Pharmacol. 2006. PMID: 16842381 Free PMC article.

9

Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily.

Arroyo E, Valenzuela B, Portilla J, Climent-Grana E, Pérez-Ruixo JJ, Merino E. Arroyo E, et al. Eur J Clin Pharmacol. 2007 Jul;63(7):669-75. doi: 10.1007/s00228-007-0299-z. Epub 2007 May 1. Eur J Clin Pharmacol. 2007. PMID: 17473920

10

Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of trabectedin (ET-743, Yondelis) induced neutropenia.

Hing J, Perez-Ruixo JJ, Stuyckens K, Soto-Matos A, Lopez-Lazaro L, Zannikos P. Hing J, et al. Clin Pharmacol Ther. 2008 Jan;83(1):130-43. doi: 10.1038/sj.clpt.6100259. Epub 2007 Jun 27. Clin Pharmacol Ther. 2008. PMID: 17597713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters